Bioanalytical aspects of clinical mass balance studies in oncology.
about
Combined quantification of paclitaxel, docetaxel and ritonavir in human feces and urine using LC-MS/MS.Pimasertib, a selective oral MEK1/2 inhibitor: absolute bioavailability, mass balance, elimination route, and metabolite profile in cancer patients.Metabolite profiling of the multiple tyrosine kinase inhibitor lenvatinib: a cross-species comparison.Metabolite profiling of 14C-omacetaxine mepesuccinate in plasma and excreta of cancer patients.
P2860
Bioanalytical aspects of clinical mass balance studies in oncology.
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
Bioanalytical aspects of clinical mass balance studies in oncology.
@en
Bioanalytical aspects of clinical mass balance studies in oncology.
@nl
type
label
Bioanalytical aspects of clinical mass balance studies in oncology.
@en
Bioanalytical aspects of clinical mass balance studies in oncology.
@nl
prefLabel
Bioanalytical aspects of clinical mass balance studies in oncology.
@en
Bioanalytical aspects of clinical mass balance studies in oncology.
@nl
P2093
P2860
P356
P1433
P1476
Bioanalytical aspects of clinical mass balance studies in oncology.
@en
P2093
Anne-Charlotte Dubbelman
Hilde Rosing
Jan H M Schellens
Jos H Beijnen
P2860
P304
P356
10.4155/BIO.11.276
P577
2011-12-01T00:00:00Z